drugset / Trial / NCT03474562

High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

NCT03474562

Phase 4 Completed 100 enrolled Yuhan Corporation
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the effect of high-dose rosuvastatin combined with telmisartan or amlodipine on glucose metabolism in ASCVD patients with impaired fasting glucose and hypertension.

Timeline

Start
2018-04-03
Primary completion
2019-06-07
Completion
2019-06-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Amlodipine Other / unclassified 10 mg
Subject Telmisartan Other / unclassified 40 mg
Subject Telmisartan Other / unclassified 80 mg
Background Rosuvastatin Small molecule 20 mg